04th week of 2009 patent applcation highlights part 31 |
Patent application number | Title | Published |
20090022614 | Method for Producing Sputtering Target Material for Ni-W Based Interlayer - There is provided a method for producing sputtering target materials which are used for a Ni—W based interlayer in a perpendicular magnetic recording medium. In this producing method, a Ni—W based alloy powder is prepared as a raw material powder. The alloy powder comprises 5 to 20 at % of W and the balance Ni and unavoidable impurities and is produced by gas atomization. The raw material powder is consolidated at a temperature ranging from 900 to 1150° C. This producing method makes it possible to significantly restrain expansion of the powder-filled billet in the consolidation step, thus efficiently producing Ni—W based sputtering target materials with stable qualities. | 2009-01-22 |
20090022615 | METHOD OF MOLDING COMPLEX STRUCTURES USING A SACRIFICIAL MATERIAL - A number of processes are described herein that can be used to form complex parts with undercuts and the like. In one embodiment, a multi-shot process is used to form the sacrificial component and inject the PIM feedstock. The processes described herein may reduce the number and/or severity of defects in the final part. | 2009-01-22 |
20090022616 | PROCESS FOR THE REFURBISHING OF A SPUTTERING TARGET - Disclosed in this specification is a process for refurbishing a spent sputtering target. The process includes the step of applying sufficient heat and axial force to the filled sputtering target to hot press the filled sputtering target such that the powdered metal fuses with the un-sputtered metal, producing a refurbished target. The process may be used to refurbish precious metal targets, such as ruthenium targets. | 2009-01-22 |
20090022617 | LOW-NICKEL AUSTENITIC STAINLESS STEEL AND METHOD FOR PRODUCING SAME - A low-nickel austenitic stainless steel is provided which comprises by weight: ≦0.08% C, 4.0˜5.0% Mn, 0.7˜1.0% Si, 3.5˜4.5% Ni, 16.0˜18.0% Cr, 3.0˜3.50% Cu, ≦0.045% S, ≦0.030% P, impurity elements in the total amount of ≦0.2%, and Fe as the balance. This low-nickel austenitic stainless steel has decreased nickel content, but retains excellent mechanical properties and corrosion resistance property. Therefore, the cost for producing the stainless steel can be reduced remarkably. The method for producing the low-nickel austenitic stainless steel is also provided. | 2009-01-22 |
20090022618 | Damping Alloy Steel Sheet and Method for Producing the Same - Provided are a steel-based damping alloy steel sheet having a thickness of 2.0 mm or less which has an excellent damping property of a loss factor of 0.030 or more, and excellent workability, without requiring plenty of elements such as Al, Si, and Cr; and a method for producing the same. Further provided is a damping alloy steel sheet having a thickness of 2.0 mm or less which has an element composition of C: 0.005% or less, Si: less than 1.0%, Mn: 0.05 to 1.5%, P: 0.2% or less, S: 0.01% or less, Sol. Al: less than 1.0%, and N: 0.005% or less, in terms of % by mass, and the remainder containing Fe and inevitable impurities, an average grain diameter of 50 to 300 μm, a maximum permeability of 4,000 or more, and a residual induction of 1.10 T or less. | 2009-01-22 |
20090022619 | Steel plate for submerged arc welding - A steel plate for submerged arc welding having good low temperature toughness at a fusion line vicinity part and a boundary with the base material in HAZ as well as at the base material and the weld metal is provided. The steel plate for submerged arc welding according to the invention contains, by mass, 0.03% to 0.09% C, 1.5% to 2.5% Mn, 0.005% to 0.025% Nb, 0.005% to 0.02% Ti, 0.01% to 0.06% Al, at most 0.0005% B, 0.001% to 0.008% N, at most 0.015% P, at most 0.015% S, and at most 0.006% O, and the balance consists of Fe and impurities. Therefore, the steel plate according to the present invention has good low temperature toughness not only at the fusion line vicinity part and the boundary with a base material in the HAZ but also in the base material and weld metal. | 2009-01-22 |
20090022620 | Copper-zinc alloy, production method and use - The invention relates to a copper-zinc alloy, consisting of (in wt %):
| 2009-01-22 |
20090022621 | BONDING WIRE - The invention relates to a gold alloy containing 99 wt. %, preferably 99.9 wt. % gold, and 1 to 1000 ppm, preferably 10 to 100 ppm calcium, and 1 to 1000 ppm, preferably 10 to 100 ppm ytterbium or europium or a mixture of ytterbium and europium, as well as a method for producing a homogeneous gold alloy containing europium and/or ytterbium. | 2009-01-22 |
20090022622 | Ternary aluminum alloy films and targets for manufacturing flat panel displays - A physical vapor deposition target for the manufacturing of flat panel displays is provided. The target includes a ternary alloy system having, by atom percent, a first component in an amount of about 90 to 99.98, wherein the first component is aluminum, a second component in an amount of about 0.01 to 2.0, wherein the second component is a rare earth element is selected from the group consisting of Nd, Ce, Dy and Gd, and a third component in an amount of about 0.01 to 8.0, wherein the third element is selected from the group consisting of Ni, Co, Mo, Sc, and Hf. | 2009-01-22 |
20090022623 | Peptides Capable of Functioning as Mimotopes for Hormonal Analytes - A purified peptide mimotope which is capable of binding specifically to an antibody specific to estradiol. Also disclosed is an immunoassay test device for the detection in a sample of estradiol, the immunoassay test device comprising a peptide mimotope of estradiol, and an antibody capable of binding specifically to the peptide mimotope to generate a detectable signal. | 2009-01-22 |
20090022624 | MICROFLUIDIC DEVICES FOR FLUID MANIPULATION AND ANALYSIS - The present invention relates to microfluidic devices and methods for manipulating and analyzing fluid samples. The disclosed microfluidic devices utilize a plurality of microfluidic channels, inlets, valves, filter, pumps, liquid barriers and other elements arranged in various configurations to manipulate the flow of a fluid sample in order to prepare such sample for analysis. | 2009-01-22 |
20090022625 | BIOCHEMICAL ANALYZER AND METHOD OF CONTROLLING INTERNAL TEMPERATURE OF THE BIOCHEMICAL ANALYZER - Provided is a biochemical analyzer in which a microfluidic biochemical assay may be performed. The analyzer includes: a microfluidic device loading space including a microfluidic device supporting unit detachably supporting a microfluidic device including an energy application region in which an energy is applied; an energy source loading space including an energy source applying the energy to the radiation application region; and an isolation wall isolating the microfluidic device loading space and the energy source loading space to prevent heat transfer between the microfluidic device loading space and the energy source loading space and including a window through which the energy can be transmitted. A method of controlling an internal temperature of the biochemical analyzer is also provided. | 2009-01-22 |
20090022626 | AUTOMATED ANALYZER - A conventional automated analyzer has a mechanism for performing a stirring operation and a mechanism for performing a pipetting operation. The mechanisms are independent of each other. The time interval between the stirring operation and the pipetting operation is at least several seconds. A solid particle starts to settle out at the time of termination of the stirring operation. In the pipetting operation, an operation for suctioning a liquid is performed during a transient period of the process in which the solid particle settles out. The suction of the liquid containing a solid particle during the transition period of the process may cause a variation in the number of solid particles contained in the liquid pipetted. The problem is solved by means for simultaneously performing an operation for stirring a liquid reagent containing a solid particle and an operation for maintaining the reagent. | 2009-01-22 |
20090022627 | Adsorption fabric and method of fabricating the same - A color-changing adsorption fabric is provided to identify an adsorption state of a type of chemical, e.g., acid, alkali or organic matter, the color change being generated through a chemical reaction between chemical solution and pH-indicator material after wiping the chemical solution with the fabric. An adsorption fabric used in wiping the chemical solution may include a material, whose color changes when contacting an acid, alkali or organic matter, thereby identifying a type of chemical solution and thus preventing or reducing a fire occurrence. The color change of the adsorption fabric used in wiping a chemical solution may be identified with the naked eye so that separating and disposing the used-adsorption fabric corresponding to a type of chemical may be easier. | 2009-01-22 |
20090022628 | APPARATUS AND METHODS FOR MICROFLUIDIC APPLICATIONS - Non-rigid tape apparatus and fabrication methods for microfluidic processing applications such as gel electrophoresis are provided, where microfluidic processing is performed on selected areas. Parts of the tape are formed by high pressure plastic film forming. Membranes and other structures are self sealing during and after penetration by pipettes and electrical probes. Rigid exoskeleton elements protect the non-rigid parts during processing and facilitate transport of the tape. | 2009-01-22 |
20090022629 | SOLID-STATE UREA BIOSENSOR - A solid-state urea biosensor may comprise a substrate, an electrically conductive layer, a PH sensing film, an ammonium ion selecting film and a ferment film. The electrically conductive layer covers the substrate. The PH sensing film has a PH value measuring zone, partially covering the electrically conductive layer, for measuring the PH value of a solution to be tested. The ammonium ion selecting film has an ammonium ion measuring zone for measuring the ammonium ion concentration. The ammonium ion selecting film partially covers the PH sensing film and exposes the PH value measuring zone. The ferment film is used for measuring the urea concentration in the solution, wherein the ferment film partially covers the ammonium ion selecting film and exposes the ammonium ion measuring zone. | 2009-01-22 |
20090022630 | MEASUREMENT SYSTEM WITH DISTRIBUTED FUNCTIONS - An analysis system is provided which comprises an integrated analysis device and a test strip magazine, for determining an analyte in a body fluid, wherein the analysis system comprises a first group comprising reusable components and a second group of components comprising a plurality of disposable articles. The second group includes non-electronic and electronic components, with critical interfaces configured between two or more such components, wherein non-electronic components can be disconnected from electronic components at a disconnection point. In one embodiment, critical interfaces are produced and tested during production of the analysis system. | 2009-01-22 |
20090022631 | SAMPLE CONTAINER - A sample container includes a cap that covers a container body holding a liquid sample containing a reagent and a test body. The cap includes an outer lid that covers the container body, an inner lid that is slidably attached to the outer lid and has an opening for dispensing the liquid sample, a shutter that has a shaft engaging with the inner lid, a translating unit that is fitted to the outer lid and translates sliding movements of the inner lid against the outer lid to rotation of the shutter around the shaft, and a pressing member that presses the shutter in a direction to close the shutter. The rotation of the shutter opens and closes a hole formed in the translating unit for dispensing the liquid sample. | 2009-01-22 |
20090022632 | Rotary Fluidized Bed Device and Method for Using Said Device - The present invention relates to a device with a rotating fluidized bed in one or a succession of cylindrical chambers, in which injectors ( | 2009-01-22 |
20090022633 | CATALYTIC CONVERTER, HOLDING MATERIAL FOR CATALYTIC CONVERTER AND PRODUCTION METHOD THEREOF - The present invention relates to a holding material for a catalytic converter including a catalyst carrier, a metal casing for receiving the catalyst carrier, and the holding material wound around the catalyst carrier and interposed in a gap between the catalyst carrier and the metal casing, the holding material including a low thermal conductivity layer, in which the low thermal conductivity layer includes: a molded material containing an inorganic powder; or a composite material of a porous substrate with an aerogel. | 2009-01-22 |
20090022634 | HOUSING FOR A COMPONENT OF AN EXHAUST SYSTEM AND METHOD OF PRODUCING SUCH A HOUSING - A housing for a component of an exhaust system, in particular for an exhaust gas purification device, has an envelope that comprises a shrunk clamping portion for the component, a transition portion that adjoins the clamping portion in an axial direction, and a connecting portion that adjoins the transition portion in the axial direction. The diameter of the connecting portion is larger than that of the clamping portion. A method of producing the housing for the component includes providing a tubular envelope, and inserting the component into the envelope. A shrinking step is then carried out in the clamping portion which terminates spaced apart from ends of the envelope as viewed in the axial direction, whereas the axial ends of the envelope are not acted upon. | 2009-01-22 |
20090022635 | High-performance cracker - A furnace for thermally cracking hydrocarbon process fluid is provided. The furnace comprises a convection section including a plurality of convection sub-sections, a radiant section comprising a plurality of radiant sub-sections, and an enclosure defining a plurality of discrete sectors. Each discrete sector of the enclosure includes a convection sub-section having at least one convection conduit for carrying hydrocarbon process fluid, at least one radiant sub-section having at least one radiant conduit connected to receive preheated hydrocarbon process fluid from the convection conduit, and a heat source configured to deliver heat into the discrete sector. Adjacent sectors of the furnace are segregated from each other, such that the heat delivered from the heat source is substantially localized in the discrete sector of the enclosure. | 2009-01-22 |
20090022636 | High al-content steel sheet excellent in workability and method of production of same - The present invention provides a high Al-content steel sheet having an excellent workability and a method of production of the same at a low cost by mass production, a high Al-content metal foil and a method of production of the same, and a metal substrate using a high Al-content metal foil, that is, a high Al-content steel sheet having an Al content of 6.5 mass % to 10 mass %, the high Al-content steel sheet characterized by having one or both of a {222} plane integration of an α-Fe crystal with respect to the surface of the steel sheet of 60% to 95% or a {200} plane integration of 0.01% to 15% and a method of production of the same, a high Al-content metal foil and a method of production of the same, and a metal substrate using a high Al-content metal foil. | 2009-01-22 |
20090022637 | Compositions, Methods and Devices for Control and Clean-Up of Hazardous Spills - Disclosed are methods for treating hazardous materials, such as those which result from an unwanted spill or leak, which comprise one or more of the steps or effects of: neutralizing the dispersed material; solidifying the dispersed material; immobilizing the material; and/or reducing the evolution of harmful or unwanted gaseous forms from the spillage, preferably using a binding agent which comprises a polyacrylate-polyacrylamide cross-linked copolymer. | 2009-01-22 |
20090022638 | Ion exchanger for winning metals of value - The present invention relates to the use of monodisperse, macroporous anion exchangers of type I or type II in hydrometallurgical processes for winning metals of value. | 2009-01-22 |
20090022639 | Method for the recovery of valuable metals and arsenic from a solution - The invention relates to a method for the treatment of material containing at least one valuable metal and arsenic to form a valuable metal-depleted scorodite sediment and a pure aqueous solution to be discharged from the process. According to the method, the valuable metals are first removed from the material to be treated and then arsenic precipitation from the solution is performed in two stages. By means of the method, the aim is to obtain as low a valuable metal content as possible in the scorodite sediment that will be formed. Likewise, the arsenic and valuable metal content of the aqueous solution that is formed during arsenic precipitation also remains so low that the water can be released into the environment. | 2009-01-22 |
20090022640 | PROCESSES FOR TREATING ALUMINIUM DROSS RESIDUES - There is provided a process for preparing aluminium chloride comprising leaching aluminium dross residues with H | 2009-01-22 |
20090022641 | MULTILAYERED CATALYST COMPOSITIONS - A layered, three-way conversion catalyst having the capability of simultaneously catalyzing the oxidation of hydrocarbons and carbon monoxide and the reduction of nitrogen oxides is disclosed. Methods of making and using the same are also provided. In one or more embodiments, the catalyst comprises three layers of catalytic material in conjunction with a carrier. A first layer comprises a platinum component on a first support; a second layer comprises a rhodium component on a second support; and a third layer comprises a palladium component and a third support. The palladium, rhodium, and/or platinum can independently be deposited on a support of high surface area refractory metal oxide, or of an oxygen storage component, or both. | 2009-01-22 |
20090022642 | Treatment method for decomposing perfluorocompound, decomposing catalyst and treatment apparatus - An object of the present invention is to improve the decomposition at low temperatures of perfluorocompounds containing only fluorine as a halogen, such as CF | 2009-01-22 |
20090022643 | SO3 REDUCTION CATALYST FOR PURIFYING AN EXHAUST GAS, PREPARATION PROCESS THEREOF, AND EXHAUST GAS PURIFYING METHOD USING THE CATALYST - To provide an SO | 2009-01-22 |
20090022644 | Method for the absorption of harmful substances and odors - Disclosed is a method for absorbing harmful substances, especially aldehydes, volatile organic compounds (VOC), and odors and permanently protecting particularly ambient air from said harmful substances. According to said method, a protein-reactive substance is provided at least in the proximity of emitters of harmful substances or potential emitters of harmful substances. | 2009-01-22 |
20090022645 | BLEACHING ACTIVATOR AND DETERGENT COMPOSITION COMPRISING THE SAME - To provide a bleaching activator capable of improving bleaching performance of a peroxy compound and the like, and a detergent composition comprising such a compound. A bleaching activator comprising Keggin heteropolyoxometalate anions, wherein the Keggin heteropolyoxometalate anions comprise a Keggin heteropolyoxometalate anion represented by the following formula (1): | 2009-01-22 |
20090022646 | Process for hydrothermal production of sodium silicate solutions and precipitated silicas - A method is provided for treating silica sand scrubs (SSS) generated and accumulated as waste in the chloride manufacturing process of titanium dioxide pigment. A hydrothermal process is used to produce sodium silicate solutions of modulus 3.0 to 3.8, and precipitated silicas. In some embodiments, the process uses two specific principal reaction stages. A sodium silicate solution having a low SiO | 2009-01-22 |
20090022647 | Process for Producing a Silicon Nitride Compound - A process for producing a silicon nitride compound is presented. A starting solution comprising fluorosilicic acid is provided. The starting solution is derived from a silicon, etching process wherein silicon is etched with a solution comprising hydrofluoric acid and where silicon powder has been removed. The starting solution is heated to yield a vapor solution comprising silicon tetrafluoride, hydrogen fluoride, and water. The hydrogen fluoride is separated from the vapor solution wherein a pure stream of silicon tetrafluoride and water vapor remain. The silicon tetrafluoride and water vapor are hydrolyzed to yield a concentrated fluorosilicic acid solution. The fluorosilicic acid is reacted with a base to yield a fluorosilicic salt. The fluorosilicic salt is heated to yield anhydrous silicon tetrafluoride. The anhydrous silicon tetrafluoride is reacted with a metal hydride to yield a monosilane. The monosilane is reacted to form a silicon compound and a silicon nitride compound. The silicon and the silicon nitride compounds are recovered. In an alternate embodiment, the hydrogen fluoride is recovered from the reaction process and reintroduced into the porous silicon etching process. | 2009-01-22 |
20090022648 | Induction fullerene producing device and producing method and induction fullerene - A device and a method capable of producing induction fullerene with high yield are provided. Nitrogen gas being an object to be induced is introduced into a plasma flow producing chamber and a high-temperature flow forming chamber to form a high-temperature plasma flow consisting of nitrogen ions and electrons. A negative voltage is applied to a grid | 2009-01-22 |
20090022649 | Method for producing ultra-thin nano-scaled graphene platelets - A method of producing ultra-thin, separated nano-scaled platelets having an average thickness no greater than 2 nm or comprising, on average, no more than 5 layers per platelet from a layered graphite material. The method comprises: (a) providing a supply of nano-scaled platelets with an average thickness of no more than 10 nm or having, on average, no more than 30 layers per platelet; and (b) intercalating the supply of nano-scaled platelets to produce intercalated nano platelets and exfoliating the intercalated nano platelets at a temperature and a pressure for a sufficient period of time to produce the ultra-thin nano-scaled platelets. The nano-scaled platelets are candidate reinforcement fillers for polymer nanocomposites. Nano-scaled graphene platelets are much lower-cost alternatives to carbon nano-tubes or carbon nano-fibers. | 2009-01-22 |
20090022650 | CARBON NANO-TUBE HAVING ELECTRONS INJECTED USING REDUCING AGENT, METHOD FOR MANUFACTURING THE SAME AND ELECTRICAL DEVICE USING THE SAME - Disclosed herein are methods for manufacturing a carbon nanotube (CNT) having electrons that are injected, with treatment with a reducing agent, a CNT manufactured according to the method, and an electric device comprising the CNT a CNT manufactured according to the method. The electronic characteristics such as the doped level and the band gap of the CNT having electrons injected therein can be widely and easily adjusted by changing the treatment conditions of the reducing agent. | 2009-01-22 |
20090022651 | Process and Apparatus for Producing Carbon Nanotube - Carbon nanotubes are more efficiently produced with a simpler apparatus. The process, which is for producing carbon nanotubes by the combustion method, is characterized by comprising: a step in which a catalyst-supporting powder comprising a base powder and a catalyst supported on the surface thereof is prepared; a step in which the catalyst-supporting powder is deposited on a porous support ( | 2009-01-22 |
20090022652 | Process for Producing Carbon Nanotube and Catalyst for Carbon Nanotube Production - Provided is a method for producing a carbon nanotube, wherein a catalyst for carbon nanotube production comprising a powdery catalyst supporting a metal on magnesia and having a bulk density of 0.30 g/mL to 0.70 g/mL, in a vertical reactor, is disposed over the whole area in a horizontal cross section direction of the reactor, in such state a carbon-containing compound flowed in a vertical direction inside the reactor is contacted with the catalyst at 500 to 1200° C., thereby carbon nanotubes of uniformity and high quality are efficiently synthesized in a large amount. | 2009-01-22 |
20090022653 | METHOD FOR PURIFYING HYDROGEN CHLORIDE - Method for purifying hydrogen chloride gas containing aromatic organic compounds, comprising at least one step of contacting the said hydrogen chloride with a scrubbing agent containing 1,2-dichlorethane. | 2009-01-22 |
20090022654 | Method for reforming hydrocarbon gas by oxyhydrogen flame and apparatus for reforming hydrocarbon gas - An objective is to reform, separate, and extract from a hydrocarbon gas such as methane, ethane, and propane. | 2009-01-22 |
20090022655 | Nanotubes for Cancer Therapy and Diagnostics - The present invention provides a novel approach to cancer therapy and diagnostics that utilizes nanotubes and other similar nanostructures as both an indirect source of radiation therapy (BNCT), and as delivery vehicles for other types of radio- and chemo-therapeutic materials, as well as imaging agents for diagnostic purposes. | 2009-01-22 |
20090022656 | Lipidated glycoprotein particles and methods of use - Lipidated micro- or macroparticles are prepared by covalently linking a glycoprotein, typically collagen, with at least one lipid. An amino group in the glycoprotein is joined with a primary amine in the lipid. These particles can be used to encapsulate active ingredients, such as drugs. | 2009-01-22 |
20090022657 | Novel CXCL8 antagonists - Novel antagonists of the chemokine CXCL8 (also known as Interleukin-8) can be obtained by generating mutants having specific combinations of non-conservative substitutions of basic amino acids located in the C-terminal region. Compounds prepared in accordance with the present invention can be used to block CXCL8 activity in vivo, thereby providing therapeutic compositions for use in the treatment or prevention of CXCL8-related diseases. | 2009-01-22 |
20090022658 | MODIFIED ANTIBODIES AND METHODS OF USE - Novel compounds, compositions and methods comprising modified antibodies are provided. In preferred embodiments the disclosed modified antibodies comprise antibodies having one or more of the constant region domains altered or deleted to afford beneficial physiological properties such as enhanced target localization and rapid blood clearance. The disclosed compounds are particularly useful for the treatment of neoplastic disorders in myelosuppressed patients. | 2009-01-22 |
20090022659 | Antibodies to TNF alpha and use thereof - The present invention is directed to antibodies and fragments thereof having binding specificity for TNF-α. Another embodiment of this invention relates to the antibodies described herein, and binding fragments thereof, comprising the sequences of the V | 2009-01-22 |
20090022660 | Cancerous disease modifying antibodies - The present invention relates to a method for producing cancerous disease modifying antibodies using a novel paradigm of screening. By segregating the anti-cancer antibodies using cancer cell cytotoxicity as an end point, the process makes possible the production of anti-cancer antibodies for therapeutic and diagnostic purposes. The antibodies can be used in aid of staging and diagnosis of a cancer, and can be used to treat primary tumors and tumor metastases. The anti-cancer antibodies can be conjugated to toxins, enzymes, radioactive compounds, and hematogenous cells. | 2009-01-22 |
20090022661 | Cancerous disease modifying antibodies - The present invention relates to a method for producing cancerous disease modifying antibodies using a novel paradigm of screening. By segregating the anti-cancer antibodies using cancer cell cytotoxicity as an end point, the process makes possible the production of anti-cancer antibodies for therapeutic and diagnostic purposes. The antibodies can be used in aid of staging and diagnosis of a cancer, and can be used to treat primary tumors and tumor metastases. The anti-cancer antibodies can be conjugated to toxins, enzymes, radioactive compounds, and hematogenous cells. | 2009-01-22 |
20090022662 | Cancerous disease modifying antibodies - The present invention relates to a method for producing cancerous disease modifying antibodies using a novel paradigm of screening. By segregating the anti-cancer antibodies using cancer cell cytotoxicity as an end point, the process makes possible the production of anti-cancer antibodies for therapeutic and diagnostic purposes. The antibodies can be used in aid of staging and diagnosis of a cancer, and can be used to treat primary tumors and tumor metastases. The anti-cancer antibodies can be conjugated to toxins, enzymes, radioactive compounds, and hematogenous cells. | 2009-01-22 |
20090022663 | ANTIBODIES AND RELATED MOLECULES THAT BIND TO 161P2F10B PROTEINS - Antibodies and molecules derived therefrom that bind to 161P2F10B protein and variants thereof, are described wherein 161P2F10B exhibits tissue specific expression in normal adult tissue, and is aberrantly expressed in the cancers listed in Table I. Consequently, 161P2F10B provides a diagnostic, prognostic, prophylactic and/or therapeutic target for cancer. The 161P2F10B gene or fragment thereof, or its encoded protein, or variants thereof, or a fragment thereof, can be used to elicit a humoral or cellular immune response; antibodies or T cells reactive with 161P2F10B can be used in active or passive immunization. | 2009-01-22 |
20090022664 | Radiolabelling via fluorination of aziridines - The present invention relates to novel compounds suitable for or already radiolabelled with | 2009-01-22 |
20090022665 | Evaluation Of Immediate-Effect Skin Molding Agents Using DISC - The present invention pertains to methods of characterizing the effects on the skin of skin-molding agents and to methods of characterizing the physical behavior of the skin-molding agents themselves. A preferred embodiment of the present invention uses a non-invasive, in vivo form of digital image speckle correlation to track deformation of human skin caused by the application of a skin-molding agent, in particular, an immediate-effect skin molding agent. The skin-molding agent may or may not be part of a composition. The application to the skin of a skin-molding agent may or may not be part of a treatment regimen. The present invention may be applied to any surface of the human body, to non-humans and to inert matter. Unlike in vitro methods and unlike invasive, in vivo methods that tension the skin with an apparatus, the present invention relies on the applied skin-molding agent to create before and after deformation images. From those images, it is possible to develop quantitative and qualitative characterizations of skin's movement and of the skin-molding agent itself. These characterizations will aid in the development of improved and/or customized skin molding agents and improved compositions comprising skin-molding agents. Generally, the data collected by the methods described herein, may also suggest improved and/or customized treatment regimens for molding the skin. | 2009-01-22 |
20090022666 | Methods and systems relating to mitochondrial DNA information - The present application relates, in general, to a system or a method for detection or treatment. In some aspects, a system includes at least one computer program for use with at least one computer system and wherein the computer program includes a plurality of instructions including but not limited to one or more instructions for making at least one correlation between mitochondrial DNA information regarding at least one person and information regarding at least one clinical trial involving the at least one person. | 2009-01-22 |
20090022667 | METHODS OF TREATING COGNITIVE DISORDERS BY INHIBITION OF Gpr12 - The present invention provides methods for screening a pharmaceutical agent for its ability to modulate long term memory formation, performance of a hippocampal-dependent cognitive task or Gpr12 function. The present invention also provides methods for modulating long term memory formation or performance of a hippocampal-dependent cognitive task by modulating Gpr12-dependent protein expression. The present invention further provides methods for treating a defect in long term memory formation by inhibiting Gpr12 function and methods for treating a defect in performance of a hippocampal-dependent cognitive task by inhibiting Gpr12 function. | 2009-01-22 |
20090022668 | Mri contrast agents endowed with concentration independent responsiveness - The present invention relates to a method for the in vivo, ex vivo, or in vitro determination of physical or chemical parameters of diagnostic interest by use of a slow tumbling paramagnetic agent that is responsive to changes of said physical or chemical parameter through changes in the R | 2009-01-22 |
20090022669 | COMPOSITIONS FOR PROTEIN DELIVERY VIA THE PULMONARY ROUTE - Novel formulations comprising therapeutic agents, a surface tension-controlling agent, and a component that comprises both a humectant and a viscosity-controlling agent for use in thermal droplet ejecting devices are disclosed. The formulations are useful for maintaining controlled and reliable dosage of the therapeutic agent via pulmonary delivery. | 2009-01-22 |
20090022670 | NOVEL COMPOUNDS - Disclosed are imidazo[1,2-a]pyridin-2-ylmethyl substituted piperidine derivatives of formula (I) | 2009-01-22 |
20090022671 | TREATMENT METHODS - Disclosed are methods of treating rhinosinusitis of the upper airway passages in patients afflicted with said disease, which comprises administering at least once-a-day to the surfaces of said passages of said patients an amount of aerosolized particles of mometasone furoate as a monotherapy effective for treating said disease. | 2009-01-22 |
20090022672 | FLUORIDE COMPOSITION AND METHODS FOR DENTAL MINERALIZATION - The present invention relates to compositions and methods for mineralizing a dental surface or subsurface including providing a composition including stabilized ACP and a source of fluoride ions. | 2009-01-22 |
20090022673 | Composition and packaging method for animal dental care - A comestible, water-based composition containing natural ingredients provides an effective amount of at least one active ingredient selected to reduce the proliferation of bacteria in the mouth of animals to treat and improve the dental health of animals. The composition can be administered to animals in the form of their daily intake of water and may be especially packaged for ready use and consumption by animals in pre-packaged and portable doses. Compositions containing natural ingredients and formulated as toothpastes for animal dental care are also provided. | 2009-01-22 |
20090022674 | COSMETIC OR DERMATOLOGICAL PREPARATIONS COMPRISING OLIGOPEPTIDES FOR LIGHTENING THE SKIN OF AGE MARKS AND/OR FOR PREVENTING TANNING OF THE SKIN, IN PARTICULAR TANNING OF THE SKIN CAUSED BY UV RADIATION - Cosmetic or pharmaceutical preparations which are distinguished by an effective content of one or more monomeric or homo- or heterodimeric or homo- or heterotrimeric or homo- or heterotetrameric oligopeptides, where these oligopeptides are based on a Structure Val-Val-Arg-Pro SEQ ID NO: 1 as homo- or heteromonomer. | 2009-01-22 |
20090022675 | ESTERS WITH WARMING PROPERTIES - A heat-generating composition comprises a substituted polyhydric alcohol and a fatty acid ester, the composition having the structure of: | 2009-01-22 |
20090022676 | Shear thinning hydrocarbon gel compositions and uses thereof - The present invention relates generally to gels that flow through an orifice. Specifically the invention relates to gels that are dispensed through a trigger spray nozzle or aerosol spray valve. Still more specifically, the invention relates to nonaquious gels containing polymers whose instantaneous viscosity reversibly decreases when the gel experiences shear loads. The invention includes spray gel compositions, methods of making spray gels and methods of dispensing gels whose viscosity exhibits an instantaneous temporary decrease in viscosity when the gel is subjected to shear force as happens when it flows through an orifice, such as a spray nozzle or aerosol valve. | 2009-01-22 |
20090022677 | Methods for identifying treatments that treat and/or prevent UV irradiation induced photoaging - Methods are provided for ascertaining and measuring RPTP-κ activity in response to insults such as UV irradiation and with respect to administration of a treatment and/or composition. Attenuation of EGFR activity by RPTP-κ affects aspects of photoaging, including damage to the skin, suppression of the immune system, DNA damage, and connective tissue degradation. Intervention with respect to the effects of photoaging can include protection of RPTP-κ from oxidation. The methods can be used for discovery of anti-aging treatments, adjuncts, or other preventative treatments, such as sunscreens. | 2009-01-22 |
20090022678 | POLYURETHANE DISPERSIONS FOR USE IN PERSONAL CARE PRODUCTS - The invention relates to an aqueous polyurethane dispersion suitable for use in personal care products, the dispersed polyurethane comprising the reaction products of:
| 2009-01-22 |
20090022679 | SOLID COSMETIC COMPOSITION - The present invention relates to a solid cosmetic composition comprising, as a structure agent, a combination consisting of a saturated straight-chain polymer and an agglutinating agent for this polymer. | 2009-01-22 |
20090022680 | OIL-IN-WATER EMULSION CONTAINING AN AMPHIPHILIC POLYMER - A composition for topical application, in the form of an oil-in-water emulsion, containing at least one nonionic emulsifier with a melting point of less than 45°C. and at least one 2-acrylamido-2-methylpropanesulfonic acid polymer. The composition shows very good stability. | 2009-01-22 |
20090022681 | Hair Care Composition - Hair care composition comprising from about 0.1% to about 20% of a sulfopropyl(meth)acrylate compound, an alpha methylene lactone, or a mixture thereof, wherein the sulfopropyl(meth)acrylate compound and the alpha methylene lactone each have a molecular weight of less than 500 grams/mole; and a dermatologically acceptable carrier. | 2009-01-22 |
20090022682 | FRAGRANCE DELIVERY SYSTEM - Disclosed are apparatuses and methodologies for respectively delivering fragrances to desired environments. Formulations including volatile methylsiloxane fluid provide a clear, VOC-exempt, low surface tension fluid that will evaporate completely at room temperature. Because methylsiloxane fluid is itself an odorless fluid, it does not obscure or alter combined fragrances being otherwise delivered. | 2009-01-22 |
20090022683 | Biodegradable and Thermosensitive Poly(Organophosphazene) Hydrogel, Preparation Method Thereof and Use Thereof - The present invention relates to a biodegradable and thermosensitive poly(organophosphazene) with a functional group, a preparation method thereof, and a use thereof for delivery of bioactive substances. According to the present invention, poly(organophosphazene) is a phosphagen-based polymer showing biodegradability, thermosensitivity, and sol-gel phase transition depending on temperature change, whereby when administered into a living body with bioactive substances such as drugs, the poly(organophosphazene) forms a gel-phase at body temperature to be capable of controlled release of the bioactive substances. Further, the poly(organophosphazene) has functional groups to chemically bind with bioactive substances through an ionic bond, covalent bond, or coordinate covalent bond to be capable of a sustained release of the bioactive substances due to its good binding property. Therefore, the poly(organophosphazene) is useful as a delivery material for bioactive substances. | 2009-01-22 |
20090022684 | Methods for hematopoietic stimulation - The present invention is directed to new methods for treating a subject in need of hematopoietic stimulation. The present invention is also directed to new methods of neutrophil stimulation in a subject in need thereof. The present invention is also directed to new methods of platelet stimulation in a subject in need thereof. The methods comprise administering to the subject an effective amount of a peptide optionally in combination of a hematopoietic growth factor, wherein the peptide is:
| 2009-01-22 |
20090022685 | Orthotopic, controllable, and genetically tractable non-human animal model for cancer - This invention provides a genetically tractable in situ non-human animal model for hepatocellular carcinoma. The model is useful, inter alia, in understanding the molecular mechanisms of liver cancer, in understanding the genetic alterations (e.g., in oncogenes and tumor suppressor genes) that lead to chemoresistance or poor prognosis, and in identifying and evaluating new therapies against hepatocellular carcinomas. The liver cancer model of this invention is made by altering hepatocytes to increase oncogene expression, to reduce tumor suppressor gene expression or both, preferably by inducible, reversible, and/or tissue specific expression of double-stranded RNA molecules that interfere with the expression of a target gene, and by transplanting the resulting hepatocytes into a recipient non-human animal. The invention further provides a method to treat cancer involving cooperative interactions between a tumor cell senescence program and the innate immune system. | 2009-01-22 |
20090022686 | PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF SYSTEMIC INFLAMMATORY RESPONSE SYNDROME - The present invention relates to the use of certain benzimidazoles for preparing a pharmaceutical composition for the treatment of systemic inflammatory response syndrome and particularly sepsis. | 2009-01-22 |
20090022687 | Novel Pharmaceuticals That Use Anti-HLA Antibodies - The present inventors tested the effects of interferons on the expression of HLA-A in cells and cell injury caused by anti-HLA class I antibodies, by using a 2D7-DB antibody as an anti-HLA class I antibody and the IM-9 cell line as the cells to be tested. As a result, the expression of HLA-A was demonstrated to be upregulated by IFNα or IFNγ, Furthermore, WST-8 assays were performed to examine the cell viability when an interferon and an anti-HLA class I antibody were used in combination. As a result, cell death activity was found to be increased by the combination of 2D7-DB and IFNα or IFNγ. | 2009-01-22 |
20090022688 | INHIBITORS OF SERINE PROTEASE, PARTICULARLY HCV NS3-NS4A PROTEASE - The present invention relates to compounds of formula I: | 2009-01-22 |
20090022689 | C4-SPIRO-PYRROLIDINE ANTIVIRALS - The present invention discloses compounds of Formula (I), or pharmaceutically acceptable salts, esters, or prodrugs thereof: | 2009-01-22 |
20090022690 | BACTERIAL TRANSLOCATION INHIBITOR AND METHOD OF INHIBITING BACTERIAL TRANSLOCATION - A bacterial translocation inhibitor containing live | 2009-01-22 |
20090022691 | BACTERIAL DELIVERY OF BIOLOGICALLY ACTIVE POLYPEPTIDES - The present invention relates to methods for the delivery of biologically active polypeptides to a subject by colonising non-pathogenic Gram negative bacteria. Also provided by this invention are methods of treating or preventing diseases by administering colonising Gram negative bacteria that express one or more biologically active polypeptides. The colonising non-pathogenic Gram negative bacteria may be administered in pharmaceutical formulations. | 2009-01-22 |
20090022692 | THERAPEUTIC AGENT FOR HEART DISEASE USING MAP KINASE TNNI3K - An object to be achieved by the present invention is to provide a therapeutic means for heart disease such as myocardial ischemia or myocardial infarction. The present invention provides a therapeutic agent for heart disease which comprises a myocardial progenitor cell expressing MAP kinase TNNI3K at a high level as an active ingredient. | 2009-01-22 |
20090022693 | METHOD FORISOLATING STEM CELLS FROM CRYOPRESERVED DENTAL TISSUE - The invention relates to a method for isolation of multipotent stem cells from dental tissue in which the stem cells are extracted from a tissue structure and then cultured. The invention also relates to stem cells isolated by means of the method according to the invention as well as bone cells and nerve cells produced by means of the method according to the invention. The invention also relates to a method for producing a bank of stem cells in which the cells are stored by means of the method according to the invention. According to the present invention, the cells of a pad-like soft tissue that can be localized beneath the papilla directly on the apical side of an extracted immature tooth are cryopreserved in the tissue structure such that the tissue structure is disintegrated to extract the stem cells only after thawing. These results show that stem cells/progenitor cells can be isolated even after cryopreservation of the source tissue and these stem cells/progenitor cells respond to osteogenic stimulation. In addition, the response of cells after cryopreservation turns out to be stronger than that without cryopreservation. | 2009-01-22 |
20090022694 | SIRT1 INHIBITION - A method of culturing cells in the presence of a SIRT1 inhibitor is described. | 2009-01-22 |
20090022695 | METHOD FOR EXPANSION OF TUMOUR-REACTIVE T-LYMPHOCYTES FOR IMMUNOTHERAPY OF PATIENTS WITH SPECIFIC CANCER TYPES - Methods for treating a patient suffering from a neoplastic disease are disclosed and described. A number of diseases can be treated under the present methods, including without limitation gall bladder cancer, hepato cellular cancer, ovarian cancer, small intestine cancer, lung cancer, mesothelioma, breast cancer, kidney cancer, pancreas cancer, prostate cancer, carcinoid cancer, leiomyosarcoma, or metastasis thereof. A general method for providing such treatment may include: 1) identifying in a patient one or more sentinel and/or metinel lymph nodes draining the neoplasm; 2) resecting the one or more nodes and, optionally all or part of the tumour or metastasis; 3) isolating tumour-reactive T-lymphocytes from said lymph nodes; 4) in vitro expanding said tumour-reactive T-lymphocytes; and 5) administering the thus obtained tumour-reactive T-lymphocytes to the patient. | 2009-01-22 |
20090022696 | METHODS FOR IMMORTALIZING CELLS - The present invention provides methods for immortalizing precursor cells that are non-terminally differentiated cells such as stem cells, said methods comprising culturing the precursor cells in the presence of a Notch agonist and one or more growth factors that support the proliferation but not differentiation of the non-terminally differentiated cells. The present invention further provides methods to induce the differentiation of immortalized cells, comprising growing the cells in the presence of a Notch agonist and at least one growth factor which supports the differentiation of the cell into a more specialized cell type. The immortalized and/or differentiated cells of the invention can be used to repopulate cell populations that have been diminished, for example as a result of infection or exposure to certain drugs. The invention further provides a cell culture comprising a population of non-terminally differentiated cells immortalized by the methods of the present invention and kits comprising reagents that promote the immortalization of precursor cells. The invention further provides methods for screening for Notch modulators and for identifying genes involved in processes of cellular differentiation. | 2009-01-22 |
20090022697 | System for the Implantation of Cardiac Staminal Cells with the "Ciuro? Method" - The system is composed of two inseparable parts that both make up one Device: I) A container for collecting staminal cells and for their growth factors which is the same as the portcat system with sylicon button to enable the entrance of the Huber needle through a hole. | 2009-01-22 |
20090022698 | Composition For Treatment Of Articular Cartilage Damage - Disclosed is a composition for the treatment of cartilage or bone damage or loss or defect. The composition comprises mesenchymal stem cells separated from umbilical cord blood and/or mesenchymal stem cells proliferated and/or differentiated. The composition also comprise chondrocytes and/or chondroblasts, or osteocytes and/or osteoblasts, differentiated from the mesenchymal stem cells separated from the umbilical cord blood. | 2009-01-22 |
20090022699 | Method Of Genotypically Modifying Cells By Administration Of RNA - A method of inducing genotypic modification in a cell, which comprises providing isolated RNA comprising RNA extractable from source tissue to the cell under conditions whereby the desired induction of genotypic modification is achieved, wherein the RNA is isolated polyA positive RNA in substantially pure form. | 2009-01-22 |
20090022700 | Cosmetic water-soluble film - The present invention relates to a composition which is in the form of a water-soluble anhydrous film comprising at least one water-soluble or water-dispersible film-forming polymer, and at least one live, in particular probiotic, microorganism. It also relates to a kit containing such a composition, as a combination with a secondary composition. | 2009-01-22 |
20090022701 | Recombinant human CLN2 protein and methods of its production and use - The present invention relates to a method for treating a patient having disorder characterized by a deficient amount of functional CLN2 protein in the affected cells, which comprises administering to the patient an amount of CLN2 protein effective to reduce or eliminate the symptoms caused by the deficiency in CLN2 protein. | 2009-01-22 |
20090022702 | METHODS FOR INTRODUCING MANNOSE 6-PHOSPHATE AND OTHER OLIGOSACHARIDES ONTO GLYCOPROTEINS - Methods to introduce highly phosphorylated mannopyranosyl oligosaccharide derivatives containing mannose 6-phosphate (M6P), or other oligosaccharides bearing other terminal hexoses, to carbonyl groups on oxidized glycans of glycoproteins while retaining their biological activity are described. The methods are useful for modifying glycoproteins, including those produced by recombinant protein expression systems, to increase uptake by cell surface receptor-mediated mechanisms, thus improving their therapeutic efficacy in a variety of applications. | 2009-01-22 |
20090022703 | Lysyl oxidase-like 1 (LOXL1) and elastogenesis - Described are methods of treating and preventing conditions associated with a loss of elastic fibers. Also provided herein are methods of screening for agents useful in treating such conditions, and animal models of conditions associated with a loss of elastic fibers. | 2009-01-22 |
20090022704 | METHOD FOR THE TREATMENT OF GOUT OR PSEUDOGOUT - The present invention relates to a new method, and the process to manufacture a medicament, for treating gout or pseudogout, comprising administering an effective amount of inhibitors blocking IL-1 or its maturation by the NALP3 inflammasome. | 2009-01-22 |
20090022705 | CHLOROPLASTS ENGINEERED TO EXPRESS PHARMACEUTICAL PROTEINS IN EDIBLE PLANTS - Disclosed herein are compositions for conferring oral tolerance in mammals to autoimmune disorders such as diabetes, as well as vectors and methods for plastid transformation of plants to produce a CTB-Pins protein for oral delivery. The invention also extends to the transformed plants, plant parts, and seeds and progeny thereof. The invention is applicable to plants edible without torrefying. Exemplified herein is the stable transformation of | 2009-01-22 |
20090022706 | SUBSTITUTED CYCLOHEXENES - Disclosed herein are substituted cyclohexene TLR4 signaling pathway modulators of Formula I, process of preparation thereof, pharmaceutical compositions thereof, and methods of use thereof. | 2009-01-22 |
20090022707 | Combinations of Antibodies Selective for a Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Receptor and Other Therapeutic Agents - An antibody of the invention interacts with human DR5 or with human DR4 to produce agonistic or antagonistic effects downstream of the receptor including inhibition of cell proliferation and apoptosis. Methods and uses for the antibodies, optionally in combination with various therapeutic agents, are detailed, including treatment of apoptosis-related disease and treatment of dysregulated cell growth. | 2009-01-22 |
20090022708 | Trefoil Factors and Methods of Treating Proliferation Disorders Using Same - The present invention relates to methods of regulation of cellular proliferation and/or survival, particularly methods for the treatment of proliferative disorders. The invention also relates to agents and compositions of use in such methods. | 2009-01-22 |
20090022709 | Control of sorbose utilization genes and uses thereof - This invention relates generally to the discovery of a novel control of sorbose utilization (CSU) genes. The invention further relates to the detection of these genes and their use in the diagnosis and treatment of fungal infections. | 2009-01-22 |
20090022710 | NUCLEAR FACTOR OF ACTIVATED T CELLS RECEPTOR - The present invention provides a novel transmembrane protein, which is a nuclear factor of activated T cells (‘NFAT’) receptor, and related compositions and methods. | 2009-01-22 |
20090022711 | METHODS OF MODULATING CELL DEATH BASED ON THE BIT-1/AES REGULATORY PATHWAY - The present invention provides a method of identifying an effective agent that alters the association of a Bit1 polypeptide with an AES polypeptide. The method is practiced by contacting a Bit1 polypeptide, or active fragment thereof, and an AES polypeptide, or active fragment thereof, with an agent under conditions that allow the Bit1 polypeptide or active fragment thereof to associate with the AES polypeptide or active fragment thereof; and detecting an altered association of the Bit1 polypeptide or active fragment thereof and the AES polypeptide or active fragment thereof, where an altered association indicates that the agent is an effective agent that alters the association of a Bit1 polypeptide with an AES polypeptide. Such an effective agent can modulate apoptosis and can be a useful therapeutic agent. | 2009-01-22 |
20090022712 | Compositions and Methods for Inhibiting Leukocyte Function - The present invention provides compositions and methods for regulating leukocyte migration and function. The present invention also provides compositions and methods for preventing and inhibiting lung injury and damage associated with neutrophil infiltration of the lung. | 2009-01-22 |
20090022713 | ANTI-PRO87299 ANTIBODIES - The present invention relates to compositions containing a novel protein and methods of using those compositions for the diagnosis and treatment of immune related disease | 2009-01-22 |